Healthcare entity
telehealth is the sole category represented across all 1 tracked stories. Louisiana v. FDA is most often covered alongside Center for Reproductive Rights, which appears in 1 of these 1 story. Louisiana v. FDA appears in 1 tracked Healthcare story from September 10, 2026.
Last mentioned: 1d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
telehealth is the sole category represented across all 1 tracked stories. Louisiana v. FDA is most often covered alongside Center for Reproductive Rights, which appears in 1 of these 1 story. Louisiana v. FDA appears in 1 tracked Healthcare story from September 10, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Louisiana v. FDA. Shared-story counts are live from our verified record — not editorial picks.
A Tucson OB-GYN reports 95% of abortion patients now choose telehealth after Arizona lifted state restrictions in February 2026. The Fifth Circuit's Louisiana v. FDA review could end that access nationally, forcing health systems to prepare for a return to in-person medication abortion.
Source: ijpr.org · wcsufm.org
Louisiana v. FDA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
